Natriuretic peptides increase beta1-adrenoceptor signalling in failing hearts through phosphodiesterase 3 inhibition.
about
Identification of small molecule NPR-B antagonists by high throughput screening--potential use in heart failure.Plasma C-type natriuretic peptide as a predictor for therapeutic response to metoprolol in children with postural tachycardia syndromeCNP-pGC-cGMP-PDE3-cAMP Signal Pathway Upregulated in Gastric Smooth Muscle of Diabetic Rats.Agents increasing cyclic GMP amplify 5-HT4-elicited positive inotropic response in failing rat cardiac ventricle.C-Type Natriuretic Peptide Improves Left Ventricular Functional Performance at Rest and Restores Normal Exercise Responses after Heart Failure.SERCA2 activity is involved in the CNP-mediated functional responses in failing rat myocardium.The concomitant coronary vasodilator and positive inotropic actions of the nitroxyl donor Angeli's salt in the intact rat heart: contribution of soluble guanylyl cyclase-dependent and -independent mechanisms.Cardiomyocyte Ca2+ dynamics: clinical perspectives.Inhibition of phosphodiesterase-3 by levosimendan is sufficient to account for its inotropic effect in failing human heart.Influence of phosphodiesterases and cGMP on cAMP generation and on phosphorylation of phospholamban and troponin I by 5-HT4 receptor activation in porcine left atrium.Cyclic GMP generated by natriuretic peptide receptor B enhances β1-adrenoceptor signaling in normal and failing hearts.Cardiac PDEs and crosstalk between cAMP and cGMP signalling pathways in the regulation of contractility.Functional evidence for an active role of B-type natriuretic peptide in cardiac remodelling and pro-arrhythmogenicity.Study of the regulation of the inotropic response to 5-HT4 receptor activation via phosphodiesterases and its cross-talk with C-type natriuretic peptide in porcine left atrium.Mathematical Modelling of Nitric Oxide/Cyclic GMP/Cyclic AMP Signalling in Platelets.Natriuretic peptide receptors and heart failure: to B or not to B blocked?
P2860
Q35057768-1B09C500-017A-4946-907D-74411A18BF57Q35219788-B57DB952-6A30-47BD-8B6B-969EF621703EQ35323516-7F762623-07F0-4373-95A5-F8C60536FA7BQ35563508-E8D09D12-73D6-43BD-97F9-8CAEE4DA470FQ36947760-487486B7-911D-43BB-A092-E773F6203D42Q37327400-B8702A86-1A9C-4286-97DE-29602110EEC3Q37665613-49017861-A82F-43BB-AF1D-C3BEF395619DQ38686480-C465B3AA-D779-44D1-BCDA-6E10C2375B37Q42198249-00C3FDE4-19DF-4DF5-ABF6-6A79BA217BB9Q44824819-3C13B5F6-81BA-4694-A33C-AB3434BE90E8Q45928769-9FF7505E-86C3-4D1D-A6D5-AE874B42EA70Q46599816-0C55B81D-0A61-477E-8F8E-B5D3BF3D8F45Q48498411-5D5C498C-1B3E-41C5-B797-380CA5F18F03Q49168980-3AC2CE5F-1204-42EE-AC96-4A2ABFC9C706Q49804607-AC6F8B2A-D547-4BD5-A2EE-006F5148A46EQ54483068-6F5C0A3D-8007-4E41-89E7-4C86C2BF84B8
P2860
Natriuretic peptides increase beta1-adrenoceptor signalling in failing hearts through phosphodiesterase 3 inhibition.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Natriuretic peptides increase ...... hosphodiesterase 3 inhibition.
@en
Natriuretic peptides increase ...... hosphodiesterase 3 inhibition.
@nl
type
label
Natriuretic peptides increase ...... hosphodiesterase 3 inhibition.
@en
Natriuretic peptides increase ...... hosphodiesterase 3 inhibition.
@nl
prefLabel
Natriuretic peptides increase ...... hosphodiesterase 3 inhibition.
@en
Natriuretic peptides increase ...... hosphodiesterase 3 inhibition.
@nl
P2093
P2860
P50
P356
P1476
Natriuretic peptides increase ...... hosphodiesterase 3 inhibition.
@en
P2093
Cam H T Nguyen
Finn Olav Levy
Jan-Bjørn Osnes
Karina Hougen
Lise R Moltzau
Tor Skomedal
P2860
P304
P356
10.1093/CVR/CVP364
P577
2009-11-09T00:00:00Z